0 followers
Emergex, a clinical-stage, privately-held biotechnology company headquartered in Abingdon, UK, with an operating subsidiary in Doylestown, Pennsylvania, USA, is pioneering the development of 100% synthetic T cell-priming immune set-point vaccine candidates that harness and direct the body’s natural... Read more
Thomas Rademacher
This company has no teams yet
Oxford Nanopore Technologies
8 followers
FUJIFILM Diosynth Biotechnologies
7 followers
QurAlis
1 follower
Strand Therapeutics
3 followers
Northzone
8 followers
Zilch
6 followers
CodeBase
3 followers
Avalere Health
3 followers
Thermo Fisher Scientific
174 followers
University of Surrey
2 followers
Biogen
120 followers
Explore companies